“…In the trial setting domain, 28 trials (77.8%) had scores that emphasized efficacy ( 13 , 14 , 32 - 36 , 40 , 43 - 49 , 51 - 55 , 57 - 60 , 62 - 65 ), six trials (16.7%) emphasized effectiveness ( 37 - 39 , 41 , 42 , 61 ), and two trials (5.5%) had a balanced emphasis between efficacy and effectiveness ( 50 , 56 ). The flexibility of intervention(s) domain had 21 trials (58.3%) that emphasized efficacy ( 33 - 36 , 38 , 40 , 43 , 44 , 46 - 48 , 50 - 52 , 54 , 55 , 58 , 60 , 62 , 63 , 65 ), nine trials (25.0%) emphasizing effectiveness ( 13 , 14 , 32 , 37 , 39 , 41 , 42 , 56 , 57 ), and six trials (16.7%) that exhibited a balanced emphasis between efficacy and effectiveness ( 45 , 49 , 53 , 59 , 61 , 64 ). Finally, the clinical relevance of experimental and comparison intervention(s) domain had 17 trials (47.2%) that emphasized efficacy ( 14 , 34 - 36 , 38 , 40 , 43 , 47 , 48 , …”